Abstract
Imaging in patients with reduced kidney function (glomerular filtration rate) raises three problems. (1) The imaging procedures (e.g., renography, CT urography, MR urography), where excretion of contrast media/isotopes is an integrated part of the examination, cannot give useful images in patients with <~30 ml/min/1.73 m2; all other procedures can be done. (2) Administration of iodine-based contrast media may cause a temporary (in most cases) decrease in kidney function (contrast nephropathy). (3) Injection of gadolinium-based contrast media may induce nephrogenic systemic fibrosis. Awareness of these issues is of utmost importance, when one takes care of patients with a glomerular filtration rate below 60 ml/min/1.73 m2. One should never deny a patient a clinically well-indicated imaging examination due to fear of contrast nephropathy or nephrogenic systemic fibrosis; denying may cause one overlooking, e.g., a tumor at a time where it might be removed. In patients with moderate or severe renal insufficiency, the relative low risk of nephrogenic systemic fibrosis against the relative high risk of intermittent contrast nephropathy should be taken into consideration before enhanced imaging; contrast nephropathy is seen after all agents, whereas nephrogenic systemic fibrosis does not occur after all agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, et al. Report of the radionuclides in Nephrourology Committee on renal clearance. J Nucl Med. 1996;37:883–90.
Stacul F, van der Molen AJ, Reimer P, Webb JAWW, Thomsen HS, Morcos SK, et al. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–41.
ESUR. www.esur.org [internet]. Vienna: European Society of Urogenital Radiology; 2013. Available from www.esur.org. Cited 26 Mar 2013.
Morcos SK, Thomsen HS. Urogenital imaging. A problem-oriented approach. West Sussex: Wiley-Blackwell; 2009.
The ad-hoc working group of ERBP, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–72.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;(Suppl 3):1–150.
Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, et al. Nephrogenic systemic fibrosis and gadolinium based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013;23:307–18.
Thomsen HS, Webb JAW, editors. Contrast media. Safety issues and ESUR guidelines. 3rd ed. Heidelberg: Springer; 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nielsen, Y.W., Marckmann, P., Thomsen, H.S. (2014). Imaging in Chronic Kidney Disease. In: Arici, M. (eds) Management of Chronic Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54637-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-54637-2_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54636-5
Online ISBN: 978-3-642-54637-2
eBook Packages: MedicineMedicine (R0)